Companies you’ll love to work for

181
companies
3,833
Jobs

Director/Senior Director/Executive Director - Program Management

Annexon Biosciences

Annexon Biosciences

Sales & Business Development
Posted 6+ months ago

Company Summary

Annexon Biosciences is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. The company’s pipeline is based on its platform technology addressing a broad spectrum of well-researched classical complement-mediated autoimmune, neurodegenerative and ophthalmic diseases triggered by aberrant activation of C1q, the initiating molecule of the classical complement pathway. Annexon is advancing a portfolio of innovative product candidates designed to block the activity of C1q and the entire classical complement pathway: ANX005 (intravenous administration), ANX007 (intravitreal administration), and ANX009 (subcutaneous administration). Annexon is deploying a disciplined, biomarker-driven strategy designed to improve the probability of technical success of its portfolio.

Desired Candidate Profile

The Director/SD/ED, Program & Portfolio Management is a proactive and effective problem solver who is intellectually curious and works exceedingly well with others. This role is responsible for managing and driving cross-functional activities required to advance a program from preclinical development through BLA or NDA submission. The winning skill set includes working effectively and efficiently with cross- functional groups including nonclinical, clinical, technical development, regulatory, manufacturing, commercial planning and finance. As a key member of the Core Team, the Director/SD/ED, Program & Portfolio Management will work closely with the Project Team Leader (PTL) to establish and execute program strategy and activities, integrate cross-functional input, synthesize team recommendations, and ensure program advancement on time and on budget. The candidate will also facilitate and lead discussions, and drive to solutions. Lastly, the Director/SD/ED, Program & Portfolio Management is expected to create and maintain consistent project documentation including project plans, timelines, trackers and communications.

Specific Responsibilities

  • In partnership with PTL and Core Team, develops and maintains integrated product development and lifecycle plans.
  • Creates and maintains project timelines that are critical tools for tracking progress against goals; closely and transparently manages the critical path of the project.
  • In partnership with PTL, leads and facilitates meetings, with the desired end goal always in mind.
  • Proactively identifies critical milestones, interdependencies, risks and resource constraints that could impact project timelines and collaborates with teams to develop appropriate solutions.
  • Ensures that programs and associated functions know priorities, and remained focused on key deliverables.
  • Responsible for Core Team documentation including meeting agendas, minutes, action item and decision trackers.
  • Ensures that all team members are fully informed and knowledgeable of project activities and status; optimizes communication within and between teams, in and outside of meetings.
  • Partners with Core Team to proactively address acute issues that arise.
  • Ensures that consistent project management tools and practices are used across team.
  • Supports continuous improvement efforts in Project Management practices at Annexon; leads department initiatives.
  • Ensures compliance with corporate policies and procedures, as well as US healthcare laws and regulations.

Key Qualifications

  • Undergraduate degree in a scientific, medical or business discipline; postgraduate qualification (e.g., Ph.D., MBA, MS) or commensurate experience is a distinct advantage.
  • A minimum of 8 years of biopharmaceutical industry experience, with at least 4 years in a Project Management function supporting highly matrixed drug development teams comprised of, but not limited to, functional area representatives from Research, CMC, Regulatory, Clinical, Marketing and Finance.
  • Solid understanding of activities critical to early and late-stage drug development projects; commercial-stage a plus.
  • Proven ability to manage complex, cross-functional development projects with Go/No Go decisions.
  • Strong problem solving skills, including ability to quickly diagnose issues and drive to answers.
  • Well-versed at scenario planning and capable of rapidly integrating new information into existing plans.
  • Ability to achieve business results with colleagues of diverse levels, functional expertise, skills and priorities.
  • Excellent meeting planning and facilitation skills.
  • Highly proficient at both building and maintaining Gantt charts, tracking systems, spreadsheets and tools that support a systematic and scalable approach to managing projects.
  • Highly organized, excellent writing and oral communication skills, motivated and analytically rigorous.
  • Experienced at partnering with team members to determine planning assumptions that drive timelines and budgets.
  • Adept at skillfully managing complex and challenging situations, including driving to clarity.
  • Team-oriented, with excellent interpersonal skills (i.e., collaboration, conflict management and negotiation).
  • Proven ability to communicate with senior leadership, both developing and delivering presentations.
  • Prior small company experience is a plus.
  • Residence in the SF Bay Area is preferred.

Annexon Biosciences requires that all employees be fully vaccinated against the Covid-19 virus. An applicant is considered fully vaccinated two weeks after their second dose in a 2-dose series, such as the Pfizer or Moderna vaccines, or two weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine. You will be required to show proof of vaccination status upon hire. The Company provides reasonable accommodations in accordance with applicable state, federal and local laws.

DIVERSITY, EQUITY, INCLUSION, BELONGING ARE IMPORTANT TO US

We believe that diversity, equity, inclusion and belonging are essential for the strength of our business and the vitality of the communities we serve.

Internally, we want to make sure all employees feel welcome, appreciated and can be themselves at Annexon. We continually educate, inform and hold accountability for improving our diversity, equity, inclusion and belonging efforts. We ensure that open and real dialogue happens on important diversity topics.

Externally, we continuously work to build our pipeline of underrepresented candidates for our workforce, enhance, recruit and develop a best-in-class, diverse, equitable and inclusive workforce; ensure that Black, LatinX and other underrepresented businesses have long-term sustainable opportunities to work with Annexon; and hold our vendors to the same standards under which we operate.

The anticipated starting salary for is the Director position is $210,000 – $225,696 per year. The anticipated starting salary for is the Senior Director position is $254,825 – $304,120 per year.The starting salary for this position will be determined based on the candidate’s education, experience, transferable skills, licenses/certifications, location, and will be reviewed on a case-by-case basis to determine the final compensation. The starting salary does not include any other potential components of the total compensation package, including bonus, equity, employer provided benefits, and perks.

Annexon Biosciences is an Equal Opportunity Employer and does not discriminate against any employee or applicant for employment based on race, color, religion, national origin, age, gender, sex, ancestry, citizenship status, mental or physical disability, genetic information, sexual orientation, veteran status, or military status. We are proud to promote a work environment where everyone, from any background, can do their best work.

Annexon Biosciences doesn’t accept unsolicited agency resumes and will not pay fees to any third-party agency or firm that doesn’t have a signed agreement with Annexon Biosciences.